2011
DOI: 10.1016/j.metabol.2011.04.013
|View full text |Cite
|
Sign up to set email alerts
|

Genetic deficiency of apolipoprotein D in the mouse is associated with nonfasting hypertriglyceridemia and hyperinsulinemia

Abstract: Apolipoprotein D (ApoD) is an atypical apolipoprotein with an incompletely understood function in the regulation of triglyceride and glucose metabolism. We have demonstrated that elevated ApoD production in mice results in improved postprandial triglyceride clearance. This work studies the role of ApoD deficiency in the regulation of triglyceride and glucose metabolism and its dependence on aging. We used ApoD knockout (ApoD-KO) mice of 3 and 21 months of age. Body weight and food intake were measured. Hepatic… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

1
19
0
1

Year Published

2013
2013
2022
2022

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 22 publications
(21 citation statements)
references
References 32 publications
(49 reference statements)
1
19
0
1
Order By: Relevance
“…In this context, we first find that mouse lifespan is not altered by ApoD deletion, in spite of the known metabolic (Do Carmo et al, 2009;Jimenez-Palomares et al, 2011;Perdomo et al, 2010) and cardiovascular (Leung et al, 2004;Tsukamoto et al, 2013) ApoD-dependent alterations, as well as the longevity regulatory functions described for invertebrate ApoD homologues (Hull-Thompson et al, 2009;Ruiz et al, 2011;Sanchez et al, 2006). However, within this normal lifespan, ApoD-KO mice clearly show signs of neurodegeneration, cognitive impairment and behavioral alterations at an age when mortality risks are still low.…”
Section: Discussionmentioning
confidence: 83%
“…In this context, we first find that mouse lifespan is not altered by ApoD deletion, in spite of the known metabolic (Do Carmo et al, 2009;Jimenez-Palomares et al, 2011;Perdomo et al, 2010) and cardiovascular (Leung et al, 2004;Tsukamoto et al, 2013) ApoD-dependent alterations, as well as the longevity regulatory functions described for invertebrate ApoD homologues (Hull-Thompson et al, 2009;Ruiz et al, 2011;Sanchez et al, 2006). However, within this normal lifespan, ApoD-KO mice clearly show signs of neurodegeneration, cognitive impairment and behavioral alterations at an age when mortality risks are still low.…”
Section: Discussionmentioning
confidence: 83%
“…It is a constituent of HDL in plasma and appears less abundant in LDL and very low‐density lipoprotein (VLDL). In addition, Apod ‐deficient mice have a reduction in lipoprotein lipase activity and induction of the hypertriglyceridemia (Jimenez‐Palomares et al ., ). Moreover, three missense mutations within APOD gene increase levels of triglycerides and decrease HDL in plasma (Desai et al ., ).…”
Section: Discussionmentioning
confidence: 97%
“…STAT3, IGFBP5, and apolipoprotein D, which are targets of osteopontin-a signaling, have been described to contribute to glucose homeostasis. Previously, these observations had been made in cell types and organs other than the breast [21-23] and had not been linked to osteopontin. Osteopontin signaling has been studied extensively.…”
Section: Discussionmentioning
confidence: 99%